TROWEPRICE > T. ROWE PRICE EQUITY SERIES, INC.
T. Rowe Price Health Sciences Portfolio
$696.98M
Avg Monthly Net Assets
$719.81M
Total Assets
$827K
Total Liabilities
$718.98M
Net Assets
T. Rowe Price Health Sciences Portfolio is a Mutual Fund in T. ROWE PRICE EQUITY SERIES, INC.
from TROWEPRICE,
based in Maryland,
United States of America.
The fund has two share classes
and monthly net assets of $696.98M.
On August 27th, 2024 it reported 226 holdings, the largest
being Eli Lilly & Co (12.1%), UnitedHealth Group Inc (6.5%) and Intuitive Surgical Inc (4.8%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Ticker | Monthly Returns (2 years) |
|---|---|---|---|
| T. Rowe Price Health Sciences Portfolio | C000005448 | QAAGZX | |
| T. Rowe Price Health Sciences Portfolio - II | C000005449 | QAAHBX |
Holdings
From latest NPORT-P, filed August 27th, 2024 for period ending June 30th, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| - EXACT SCIENCES CMO MILESTONE PP (Exact Sciences Corp) | Long | Equity-common | US | $95K | 167K | 0.01 |
| 10X GENOMICS INC | Long | Equity-common | US | $1M | 63K | 0.17 |
| ACADIA PHARMACEUTICALS INC | Long | Equity-common | US | $107K | 7K | 0.01 |
| AFFINIVAX AFX3772 MILESTONE EVENT PP | Long | Equity-common | US | $199K | 332K | 0.03 |
| AFFINIVAX EXPENSE FUND PP | Long | Equity-common | US | $534.04 | 562.15 | 0.00 |
| AFFINIVAX NEXT GEN PROD MILESTON EVNT PP | Long | Equity-common | US | $76K | 332K | 0.01 |
| AGILENT TECHNOLOGIES INC | Long | Equity-common | US | $5M | 39K | 0.71 |
| AGILON HEALTH INC | Long | Equity-common | US | $137K | 21K | 0.02 |
| AGIOS PHARMACEUTICALS INC | Long | Equity-common | US | $3M | 60K | 0.36 |
| AKERO THERAPEUTICS INC | Long | Equity-common | US | $812K | 35K | 0.11 |
| ALECTOR INC | Long | Equity-common | US | $138K | 30K | 0.02 |
| ALLOGENE THERAPEUTICS INC | Long | Equity-common | US | $507K | 218K | 0.07 |
| ALNYLAM PHARMACEUTICALS INC | Long | Equity-common | US | $16M | 65K | 2.19 |
| AMGEN INC | Long | Equity-common | US | $17M | 54K | 2.35 |
| ANAPTYSBIO INC | Long | Equity-common | US | $238K | 10K | 0.03 |
| APELLIS PHARMACEUTICALS INC | Long | Equity-common | US | $953K | 25K | 0.13 |
| APOGEE THERAPEUTICS INC | Long | Equity-common | US | $1M | 27K | 0.15 |
| ARBOR BIO SERIES B CVT PFD STOCK PP | Long | Equity-preferred | US | $398K | 24K | 0.06 |
| ARCELLX INC | Long | Equity-common | US | $2M | 28K | 0.21 |
| ARDELYX INC | Long | Equity-common | US | $410K | 55K | 0.06 |
| ARGENX SE | Long | Equity-common | NL | $15M | 36K | 2.15 |
| ARVINAS INC | Long | Equity-common | US | $692K | 26K | 0.10 |
| ASCENDIS PHARMA A/S | Long | Equity-common | DK | $4M | 28K | 0.54 |
| ASTRAZENECA PLC | Long | Equity-common | GB | $18M | 233K | 2.53 |
| ATARA BIOTHERAPEUTICS INC | Short | Equity-common | US | $-8.5 | -1 | -0.00 |
| AURA BIOSCIENCES INC | Long | Equity-common | US | $135K | 18K | 0.02 |
| AVALYN PHARMA SER C-1 CVT PFD STOCK PP | Long | Equity-preferred | US | $285K | 389K | 0.04 |
| AVIDITY BIOSCIENCES INC | Long | Equity-common | US | $6M | 146K | 0.83 |
| BECTON DICKINSON & CO | Long | Equity-common | US | $8M | 34K | 1.09 |
| BEIGENE LTD | Long | Equity-common | KY | $4M | 31K | 0.62 |
| BICYCLE THERAPEUTICS PLC | Long | Equity-common | GB | $559K | 28K | 0.08 |
| BICYCLE THERAPEUTICS PLC-ADR PIPE PP | Long | Equity-common | US | $752K | 39K | 0.10 |
| BIO-TECHNE CORP | Long | Equity-common | US | $4M | 55K | 0.55 |
| BIOGEN INC | Long | Equity-common | US | $3M | 12K | 0.39 |
| BIOHAVEN LTD | Long | Equity-common | VG | $3M | 82K | 0.40 |
| BIOMARIN PHARMACEUTICAL INC | Long | Equity-common | US | $3M | 32K | 0.37 |
| BLUEJAY THERAPEUTICS SER C CVT PFD PP | Long | Equity-preferred | US | $850K | 130K | 0.12 |
| BLUEPRINT MEDICINES CORP | Long | Equity-common | US | $9M | 86K | 1.30 |
| BOSTON SCIENTIFIC CORP | Long | Equity-common | US | $11M | 145K | 1.55 |
| BRUKER CORP | Long | Equity-common | US | $936K | 15K | 0.13 |
| CAPSULE CORP SERIES 1-D CVT PFD STOCK | Long | Equity-preferred | US | $87K | 38K | 0.01 |
| CAPSULE CORP SERIES E CVT PFD STOCK PP | Long | Equity-preferred | US | $93K | 41K | 0.01 |
| CARDINAL HEALTH INC | Long | Equity-common | US | $2M | 18K | 0.25 |
| CARGO THERAPEUTICS INC | Long | Equity-common | US | $1M | 82K | 0.19 |
| CARIS LIFE SCIENCES SER C CVT PFD PP (Caris Life Sciences Inc) | Long | Equity-preferred | US | $616K | 169K | 0.09 |
| CARIS LIFE SER D CVT PFD STOCK PP (Caris Life Sciences Inc) | Long | Equity-preferred | US | $371K | 102K | 0.05 |
| CELLANOME SERIES A CVT PFD STOCK PP | Long | Equity-preferred | US | $673K | 90K | 0.09 |
| CELLDEX THERAPEUTICS INC | Long | Equity-common | US | $2M | 54K | 0.28 |
| CENCORA INC | Long | Equity-common | US | $1M | 5K | 0.16 |
| CENTENE CORP | Long | Equity-common | US | $2M | 37K | 0.34 |
| CENTESSA PHARMACEUTICALS PLC | Long | Equity-common | GB | $818K | 91K | 0.11 |
| CHROMA MEDICINE SER B CVT PFT STOCK PP | Long | Equity-preferred | US | $198K | 76K | 0.03 |
| CHROMA MEDICINE SERIES A CVT PFD STOCK P | Long | Equity-preferred | US | $613K | 236K | 0.09 |
| CHROMACODE INC SR D-1 CVT PFD STOCK PP | Long | Equity-preferred | US | $30K | 141K | 0.00 |
| CHROMACODE INC SR D-2 CVT PFD STOCK PP | Long | Equity-preferred | US | $65K | 141K | 0.01 |
| CIGNA GROUP/THE | Long | Equity-common | US | $12M | 37K | 1.69 |
| CLEAR LABS SERIES C CVT PFD PP | Long | Equity-preferred | US | $106K | 171K | 0.01 |
| CLEERLY SER C CVT PFD STK PP | Long | Equity-preferred | US | $238K | 27K | 0.03 |
| COLOR HEALTH SER D CVT PFD STOCK PP | Long | Equity-preferred | US | $236K | 13K | 0.03 |
| COLOR HEALTH SERIES D-1 CVT PFD STOCK PP | Long | Equity-preferred | US | $242K | 20K | 0.03 |
| COLOR HEALTH SERIES E CVT PFD STOCK PP | Long | Equity-preferred | US | $79K | 2K | 0.01 |
| CRINETICS PHARMACEUTICALS INC | Long | Equity-common | US | $2M | 47K | 0.29 |
| CYTOKINETICS INC | Long | Equity-common | US | $962K | 18K | 0.13 |
| DAIICHI SANKYO CO LTD | Long | Equity-common | JP | $2M | 48K | 0.23 |
| DANAHER CORP | Long | Equity-common | US | $24M | 98K | 3.39 |
| DAY ONE BIOPHARMACEUTICALS INC | Long | Equity-common | US | $42K | 3K | 0.01 |
| DELFI DIAGNOSTICS SR A CVT PFD STOCK PP | Long | Equity-preferred | US | $749K | 155K | 0.10 |
| DELFI DIAGNOSTICS SR B CVT PFD STOCK PP | Long | Equity-preferred | US | $408K | 84K | 0.06 |
| DENALI THERAPEUTICS INC | Long | Equity-common | US | $1M | 51K | 0.16 |
| DEXCOM INC | Long | Equity-common | US | $4M | 33K | 0.51 |
| DISC MEDICINE INC | Long | Equity-common | US | $520K | 12K | 0.07 |
| DNA SCRIPT SERIES C CVT PFD STOCK PP (DNA Script SAS) | Long | Equity-preferred | FR | $350K | 1K | 0.05 |
| DYNE THERAPEUTICS INC | Long | Equity-common | US | $2M | 43K | 0.21 |
| EDWARDS LIFESCIENCES CORP | Long | Equity-common | US | $10M | 104K | 1.33 |
| EIKON THERA SERIES B CVT PFD STOCK PP | Long | Equity-preferred | US | $984K | 46K | 0.14 |
| EIKON THERAPEUTICS SER C CVT PFD STK PP | Long | Equity-preferred | US | $195K | 9K | 0.03 |
| ELEMENT BIOSCIENCES SER C CVT PFD STOCK | Long | Equity-preferred | US | $376K | 39K | 0.05 |
| ELEMENT BIOSCIENCES SER D CVT PFD PP | Long | Equity-preferred | US | $106K | 14K | 0.01 |
| ELEMENT BIOSCIENCES SER D-1 CVT PFD PP | Long | Equity-preferred | US | $106K | 14K | 0.01 |
| ELEVANCE HEALTH INC | Long | Equity-common | US | $27M | 50K | 3.74 |
| ELI LILLY & CO | Long | Equity-common | US | $87M | 96K | 12.09 |
| END EAVOR BIO SERIES B CVT PFD STOCK PP | Long | Equity-preferred | US | $550K | 84K | 0.08 |
| ENDEAVOR BIO SER C CVT PFD PP | Long | Equity-preferred | US | $154K | 24K | 0.02 |
| ENTRADA THERAPEUTICS INC | Long | Equity-common | US | $283K | 20K | 0.04 |
| EXACT SCIENCES CORP | Long | Equity-common | US | $1M | 33K | 0.19 |
| EXACT SCIENCES FDA MILESTONE PP (Exact Sciences Corp) | Long | Equity-common | US | $48K | 84K | 0.01 |
| FOG PHARMA SER D CVT PFD STOCK PP | Long | Equity-preferred | US | $202K | 28K | 0.03 |
| FOG PHARMA SER E CVT PFD PP | Long | Equity-preferred | US | $93K | 15K | 0.01 |
| FOG PHARMACEUTICALS SERIES C CVT PFD STOCK PP | Long | Equity-preferred | US | $165K | 19K | 0.02 |
| FREENOME HOLDINGS SER B CVT PFD PP (Freenome Inc) | Long | Equity-preferred | US | $396K | 71K | 0.06 |
| FREENOME HOLDINGS SER C CVT PFD PP (Freenome Inc) | Long | Equity-preferred | US | $232K | 42K | 0.03 |
| FREENOME HOLDINGS SER D CVT PFD PP (Freenome Inc) | Long | Equity-preferred | US | $132K | 24K | 0.02 |
| FREENOME HOLDINGS SER F CVT PFD PP (Freenome Inc) | Long | Equity-preferred | US | $47K | 9K | 0.01 |
| GALVANIZE THERAPEUTICS CVT PROM NOTE PP | Long | Debt | US | $295K | – | 0.04 |
| GENEDX HOLDINGS CORP | Long | Equity-common | US | $51K | 2K | 0.01 |
| GENEDX HOLDINGS CORP | Long | Equity-common | US | $338.46 | 11K | 0.00 |
| GENERATE BIO SER B CVT PFD STOCK PP | Long | Equity-preferred | US | $1M | 84K | 0.14 |
| GENERATE BIOMEDICINES INC SER C CVT PFD | Long | Equity-preferred | US | $201K | 17K | 0.03 |
| GENERATION BIO CO | Long | Equity-common | US | $258K | 91K | 0.04 |
| GENESIS THERA SER A CVT PFD STOCK PP | Long | Equity-preferred | US | $191K | 37K | 0.03 |
| GENESIS THERA SEV B CVT PFD STOCK PP | Long | Equity-preferred | US | $465K | 91K | 0.06 |
| Ginkgo Bioworks Holdings Earn Out Shares $15.00 PP | Long | Equity-common | US | $168 | 10K | 0.00 |
| Ginkgo Bioworks Holdings Earn Out Shares $17.50 PP | Long | Equity-common | US | $130.13 | 10K | 0.00 |
| Ginkgo Bioworks Holdings Earn Out Shares $20.00 PP | Long | Equity-common | US | $103.26 | 10K | 0.00 |
| GINKGO BIOWORKS HOLDINGS INC | Long | Equity-common | US | $31K | 91K | 0.00 |
| GUARDANT HEALTH INC | Long | Equity-common | US | $279K | 10K | 0.04 |
| GYROSCOPE THERAPEUTICS MILESTONE PAYMENT 1 PP (Gyroscope Therapeutics Ltd) | Long | Equity-common | US | $0 | 253K | – |
| GYROSCOPE THERAPEUTICS MILESTONE PAYMENT 2 PP (Gyroscope Therapeutics Ltd) | Long | Equity-common | US | $0 | 169K | – |
| GYROSCOPE THERAPEUTICS MILESTONE PAYMENT 3 PP (Gyroscope Therapeutics Ltd) | Long | Equity-common | US | $0 | 169K | – |
| HCA HEALTHCARE INC | Long | Equity-common | US | $8M | 24K | 1.06 |
| HOLOGIC INC | Long | Equity-common | US | $3M | 41K | 0.42 |
| HONOR TECHNOLOGY SER D CVT PFD PP | Long | Equity-preferred | US | $241K | 141K | 0.03 |
| HONOR TECHNOLOGY SER E CVT PFD STOCK PP | Long | Equity-preferred | US | $162K | 95K | 0.02 |
| HUMANA INC | Long | Equity-common | US | $4M | 11K | 0.59 |
| ICON PLC | Long | Equity-common | IE | $4M | 14K | 0.61 |
| IDEAYA BIOSCIENCES INC | Long | Equity-common | US | $1M | 33K | 0.16 |
| IGM BIOSCIENCES INC | Long | Equity-common | US | $317K | 46K | 0.04 |
| IMMATICS NV | Long | Equity-common | NL | $813K | 70K | 0.11 |
| IMMUNEERING CORP | Long | Equity-common | US | $37K | 29K | 0.01 |
| IMMUNOCORE HOLDINGS PLC | Long | Equity-common | GB | $2M | 64K | 0.30 |
| IMMUNOCORE HOLDINGS PLC | Long | Debt | GB | $617K | – | 0.09 |
| IMMUNOME INC | Long | Equity-common | US | $875K | 72K | 0.12 |
| INSCRIPTA SERIES E CVT PFD STOCK PP | Long | Equity-preferred | US | $121K | 65K | 0.02 |
| INSITRO SER B CVT PFD PP | Long | Equity-preferred | US | $728K | 40K | 0.10 |
| INSITRO SER C CVT PFD PP | Long | Equity-preferred | US | $481K | 26K | 0.07 |
| INSMED INC | Long | Equity-common | US | $8M | 126K | 1.17 |
| INSPIRE MEDICAL SYSTEMS INC | Long | Equity-common | US | $1M | 8K | 0.14 |
| INSULET CORP | Long | Equity-common | US | $1M | 7K | 0.21 |
| INTUITIVE SURGICAL INC | Long | Equity-common | US | $34M | 77K | 4.78 |
| IONIS PHARMACEUTICALS INC | Long | Equity-common | US | $2M | 45K | 0.30 |
| IOVANCE BIOTHERAPEUTICS INC | Long | Equity-common | US | $649K | 81K | 0.09 |
| KARDIUM INC CB CVT PROM NOTE PP | Long | Debt | CA | $257K | – | 0.04 |
| KARDIUM INC SER D-5 CVT PFD STOCK PP | Long | Equity-preferred | US | $343K | 404K | 0.05 |
| KARDIUM SERIES D6 CVT PFD STOCK PP | Long | Equity-preferred | US | $473K | 557K | 0.07 |
| KARTOS THERAPEUTICS SR C CVT PFD STK PP | Long | Equity-preferred | US | $486K | 86K | 0.07 |
| KRYSTAL BIOTECH INC | Long | Equity-common | US | $3M | 16K | 0.42 |
| KYMERA THERAPEUTICS INC | Long | Equity-common | US | $2M | 59K | 0.25 |
| LANTHEUS HOLDINGS INC | Long | Equity-common | US | $977K | 12K | 0.14 |
| LARONDE SERIES B CVT PFD STOCK PP | Long | Equity-preferred | US | $221K | 53K | 0.03 |
| LEGEND BIOTECH CORP | Long | Equity-common | KY | $2M | 40K | 0.25 |
| LONGBOARD PHARMACEUTICALS INC | Long | Equity-common | US | $1M | 48K | 0.18 |
| LUMICKS TECH SER D CVT PFD STOCK PP | Long | Equity-preferred | US | $201K | 221 | 0.03 |
| LYELL IMMUNOPHARMA INC | Long | Equity-common | US | $414K | 285K | 0.06 |
| MADRIGAL PHARMACEUTICALS INC | Long | Equity-common | US | $4M | 16K | 0.62 |
| MCKESSON CORP | Long | Equity-common | US | $3M | 5K | 0.44 |
| MERCK & CO INC | Long | Equity-common | US | $28M | 228K | 3.93 |
| MODERNA INC | Long | Equity-common | US | $544K | 5K | 0.08 |
| MOLINA HEALTHCARE INC | Long | Equity-common | US | $7M | 25K | 1.03 |
| MONTE ROSA THERAPEUTICS INC | Long | Equity-common | US | $198K | 53K | 0.03 |
| MOONLAKE IMMUNOTHERAPEUTICS | Long | Equity-common | KY | $3M | 59K | 0.36 |
| MORPHIC HOLDING INC | Long | Equity-common | US | $975K | 29K | 0.14 |
| NATIONAL RESILIENCE SER B CVT PFD STOCK | Long | Equity-preferred | US | $3M | 54K | 0.35 |
| NATIONAL RESILIENCE SER C CVT PFD STOCK | Long | Equity-preferred | US | $893K | 19K | 0.12 |
| NEUROCRINE BIOSCIENCES INC | Long | Equity-common | US | $5M | 36K | 0.69 |
| NOVO NORDISK A/S | Long | Equity-common | DK | $12M | 86K | 1.71 |
| NOVOCURE LTD | Long | Equity-common | JE | $1M | 75K | 0.18 |
| NUTCRACKER THERA SER C CVT PFD STOCK PP | Long | Equity-preferred | US | $501K | 47K | 0.07 |
| OBSIDIAN THERAPEUTICS SR C CVT PFD STK PP | Long | Equity-preferred | US | $422K | 222K | 0.06 |
| ODYSSEY THERAPEUTICS SR B CVT PFD STK PP | Long | Equity-preferred | US | $263K | 51K | 0.04 |
| ODYSSEY THERAPEUTICS SR C CVT PFD STK PP | Long | Equity-preferred | US | $25K | 5K | 0.00 |
| ORCHESTRA BIOMED HOLDINGS INC | Long | Equity-common | US | $202K | 25K | 0.03 |
| PACIFIC BIOSCIENCES OF CALIFORNIA INC | Long | Equity-common | US | $111K | 81K | 0.02 |
| PAX LABS CLASS A COMMON PP (PAX Labs Inc) | Long | Equity-common | US | $154K | 386K | 0.02 |
| PENUMBRA INC | Long | Equity-common | US | $6M | 35K | 0.88 |
| PLIANT THERAPEUTICS INC | Long | Equity-common | US | $296K | 28K | 0.04 |
| PRELUDE THERAPEUTICS INC | Long | Equity-common | US | $151K | 40K | 0.02 |
| PROCEPT BIOROBOTICS CORP | Long | Equity-common | US | $1M | 19K | 0.16 |
| PROFOUNBIO ESCROW FUND PAYMENT | Long | Equity-preferred | US | $32K | 34K | 0.00 |
| PROFOUNDBIO EXPENSE FUND PYMT | Long | Equity-preferred | US | $106.49 | 112.09 | 0.00 |
| PROGNOMIQ SER B CVT PFD STOCK | Long | Equity-preferred | US | $514K | 168K | 0.07 |
| PROGNOMIQ SER C CVT PFD STOCK PP | Long | Equity-preferred | US | $157K | 51K | 0.02 |
| PrognomIQ Series A-4 Pfd | Long | Equity-preferred | US | $82K | 27K | 0.01 |
| PROTAGONIST THERAPEUTICS INC | Long | Equity-common | US | $1M | 41K | 0.20 |
| PROTHENA CORP PLC | Long | Equity-common | IE | $575K | 28K | 0.08 |
| RAPPORT THERAPEUTICS INC | Long | Equity-common | US | $655K | 28K | 0.09 |
| RAPT THERAPEUTICS INC | Long | Equity-common | US | $10K | 3K | 0.00 |
| REFLEXION MEDICAL INC CVT | Long | Equity-preferred | US | $89K | 51K | 0.01 |
| REFLEXION MEDICAL INC CVT PFD SR C PP | Long | Equity-preferred | US | $259K | 151K | 0.04 |
| REFLEXION MEDICAL INC PP | Long | Equity-preferred | US | $110K | 83K | 0.02 |
| REFLEXION MEDICAL INC SR E CVT PFD PP | Long | Equity-preferred | US | $151K | 84K | 0.02 |
| REGENERON PHARMACEUTICALS INC | Long | Equity-common | US | $23M | 22K | 3.15 |
| RELAY THERAPEUTICS INC | Long | Equity-common | US | $382K | 59K | 0.05 |
| REPLIGEN CORP | Long | Equity-common | US | $1M | 11K | 0.20 |
| REPLIMUNE GROUP INC | Long | Equity-common | US | $616K | 68K | 0.09 |
| REPLIMUNE GROUP INC PIPE PP | Long | Equity-common | US | $68K | 8K | 0.01 |
| REVOLUTION MEDICINES INC | Long | Equity-common | US | $3M | 71K | 0.38 |
| REVOLUTION MEDICINES INC | Long | Equity-common | US | $791.14 | 11K | 0.00 |
| RING THERA SER B CVT PFD STOCK PP | Long | Equity-preferred | US | $404K | 44K | 0.06 |
| RING THERAPEUTICS SER C CVT PFD STK PP | Long | Equity-preferred | US | $198K | 21K | 0.03 |
| ROCKET PHARMACEUTICALS INC | Long | Equity-common | US | $1M | 50K | 0.15 |
| SAGE THERAPEUTICS INC | Long | Equity-common | US | $157K | 14K | 0.02 |
| SALIOGEN THERA SERIES B CVT PFD STOCK PP | Long | Equity-preferred | US | $273K | 5K | 0.04 |
| SALUDA MEDICAL INC SERIES E CVT PFD PP | Long | Equity-preferred | US | $235K | 24K | 0.03 |
| SALUDA MEDICAL SERIES D CVT PFD STOCK PP | Long | Equity-preferred | US | $331K | 31K | 0.05 |
| SALUDA MEDICAL WTS 1/23 PP | Long | Equity-common | US | $9K | 5K | 0.00 |
| SANA BIOTECHNOLOGY INC | Long | Equity-common | US | $627K | 115K | 0.09 |
| SAREPTA THERAPEUTICS INC | Long | Equity-common | US | $807K | 5K | 0.11 |
| SARTORIUS AG | Long | Equity-preferred | DE | $1M | 5K | 0.16 |
| SCHOLAR ROCK HOLDING CORP | Long | Equity-common | US | $683K | 82K | 0.10 |
| SCHOLAR ROCK WTS 12.25 PP (Scholar Rock Holding Corp) | Long | Equity-common | US | $20K | 7K | 0.00 |
| SCRIBE THERA SER B CVT PFD STOCK PP | Long | Equity-preferred | US | $278K | 46K | 0.04 |
| Series A-5 CVT Pfd | Long | Equity-preferred | US | $71K | 23K | 0.01 |
| SIEMENS HEALTHINEERS AG | Long | Equity-common | DE | $723K | 13K | 0.10 |
| SIONNA THERAPEUTICS SR B CVT PFD STK PP | Long | Equity-preferred | US | $239K | 24K | 0.03 |
| SIONNA THERAPEUTICS SR C CVT PFD PP | Long | Equity-preferred | US | $84K | 9K | 0.01 |
| SOMALOGIC INC | Long | Equity-common | US | $98.74 | 5K | 0.00 |
| SPRINGWORKS THERAPEUTICS INC | Long | Equity-common | US | $2M | 49K | 0.26 |
| SPYRE THERAPEUTICS INC | Long | Equity-common | US | $235K | 10K | 0.03 |
| STRUCTURE THERAPEUTICS INC | Long | Equity-common | KY | $2M | 54K | 0.30 |
| STRYKER CORP | Long | Equity-common | US | $26M | 75K | 3.56 |
| SURGERY PARTNERS INC | Long | Equity-common | US | $253K | 11K | 0.04 |
| T. Rowe Price Government Reserve Fund | Long | Short-term investment vehicle | US | $3M | 3M | 0.36 |
| TEMPUS LABS INC CVT PFD SR D PP | Long | Equity-preferred | US | $5M | 129K | 0.63 |
| TENET HEALTHCARE CORP | Long | Equity-common | US | $6M | 41K | 0.77 |
| TESSERA THERAPEUTICS SR C CVT PFD STK PP | Long | Equity-preferred | US | $357K | 17K | 0.05 |
| THERMO FISHER SCIENTIFIC INC | Long | Equity-common | US | $32M | 57K | 4.41 |
| TREELINE BIO SER A CVT PFD STOCK PP | Long | Equity-preferred | US | $830K | 106K | 0.12 |
| ULTRAGENYX PHARMACEUTICAL INC | Long | Equity-common | US | $2M | 42K | 0.24 |
| UNITEDHEALTH GROUP INC | Long | Equity-common | US | $46M | 91K | 6.46 |
| VAXCYTE INC | Long | Equity-common | US | $3M | 41K | 0.43 |
| VERILY LIFE SCIENCES LLC SER B UNITS PP | Long | Equity-common | US | $509K | 5K | 0.07 |
| VERTEX PHARMACEUTICALS INC | Long | Equity-common | US | $18M | 39K | 2.54 |
| VOYAGER THERAPEUTICS INC | Long | Equity-common | US | $339K | 43K | 0.05 |
| XENCOR INC | Long | Equity-common | US | $769K | 41K | 0.11 |
| ZAI LAB LTD | Long | Equity-common | KY | $1M | 60K | 0.14 |
| ZENTALIS PHARMACEUTICALS INC | Long | Equity-common | US | $119K | 29K | 0.02 |
Address
T. ROWE PRICE EQUITY SERIES, INC.
100 East Pratt Street
Baltimore
Maryland
21202
United States of America
Websites
Directors
Bruce W. Duncan
David Oestreicher
Eric L. Veiel
Kellye L. Walker
Mark J. Parrell
Melody Bianchetto
Paul F. McBride
Robert J. Gerrard, Jr.
Teresa Bryce Bazemore
Transfer Agents
T. Rowe Price Retirement Plan Services, Inc.
T. Rowe Price Services, Inc.
Pricing Services
Bloomberg Finance L.P.
ICE Data Services, Inc.
London Stock Exchange Group PLC
S&P Global Inc.
Custodians
BNP Paribas
Deutsche Bank AG, Hungary branch
Deutsche Bank Aktiengesellschaft
EUROCLEAR BANK SA/NV
HSBC Bank Middle East Ltd. (UAE)
J.P. Morgan Bank Luxembourg S.A.
J.P. Morgan Saudi Arabia Limited
JPMorgan Chase Bank, London
JPMorgan Chase Bank, N.A. - Dublin Branch
JPMorgan Chase Bank, N.A.
JPMorgan Chase Bank, N.A. - New Zealand Branch
JPMorgan Chase Bank, N.A. - Sydney Branch
Mizuho Bank, Ltd.
Royal Bank of Canada
Santander Securities Services, S.A.
Standard Chartered Bank Korea Limited
State Street Bank and Trust Company
The Hongkong and Shanghai Banking Corporation Limited - Manila Branch
UBS Switzerland AG
UniCredit Bank Czech Republic and Slovakia, a.s.
Shareholder Servicing Agents
T. Rowe Price Retirement Plan Services, Inc.
T. Rowe Price Services, Inc.
Admins
T. Rowe Price Associates, Inc.
Brokers
BARCLAYS CAPITAL INC.
BMO Capital Markets Corp.
BOFA SECURITIES, INC.
Citigroup Inc.
EVERCORE GROUP L.L.C.
GOLDMAN SACHS & CO. LLC
J.P. MORGAN SECURITIES LLC
MORGAN STANLEY & CO. LLC
RBC Capital Markets, LLC
UBS AG